NCT06197438 2024-01-09Phase II Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab in Advanced Gastric CancerFujian Cancer HospitalPhase 2 Unknown36 enrolled
NCT05839470 2023-11-15Cadonilimab Plus FOLFOXIRI and Bevacizumab as First Line Therapy for Metastatic MSS Colorectal CancerFujian Cancer HospitalPhase 2 Unknown20 enrolled